Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Gauss Surgical

Request full access

The world's first real-time monitoring system for surgical blood loss

Menlo Park, United StatesFounded 2011Biotech & Life Sciences

About Gauss Surgical

Gauss Surgical, established in 2011, developed a platform to address the critical unmet need for accurate, real-time measurement of blood loss in surgical and obstetric settings. The company was founded by Siddarth Satish, who was inspired to create a technological solution after observing the imprecise visual estimation methods used in operating rooms. Satish, who holds degrees in Chemical Engineering and Bioengineering, founded the company after his graduate work at UC Berkeley and UCSF and a fellowship at Stanford University School of Medicine, where he identified the opportunity to apply computer vision to this longstanding clinical challenge.

The company's flagship product, Triton, is an artificial intelligence-powered platform that uses a mobile device's camera, initially an iPad or iPhone, to scan surgical sponges and fluid-filled canisters. Its computer vision and machine learning algorithms then analyze the images to provide clinicians with an accurate, real-time quantification of a patient's blood loss. This system was designed to replace subjective visual guesswork, which is notoriously inaccurate and can lead to delayed intervention in hemorrhage situations, a leading cause of preventable maternal mortality. By providing precise data, Triton enables earlier recognition of hemorrhage, leading to more timely and appropriate blood transfusions, which can improve patient outcomes and reduce hospital stays.

Gauss Surgical operated on a software-as-a-service (SaaS) business model, providing its HIPAA-compliant platform to hospitals and health systems. The company achieved significant milestones, including receiving De Novo clearance from the U.S. Food and Drug Administration (FDA) in 2014, marking it as the first computer vision software approved for surgical use. It also secured CE Mark approval in Europe and won an Apple Design Award. The company raised substantial venture capital, including a $20 million Series C round in 2018 with investments from strategic partners like Northwell Health and SoftBank Ventures Korea, to accelerate adoption and development. In a strategic move to broaden its impact, medical technology giant Stryker acquired Gauss Surgical in September 2021.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
7
Open positions
None listed
Dealroom signal
61.6/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotechnology, Surgery, Core AI, Spinout, AI Applications, DT and LS, science-based
Technology
Artificial Intelligence, Deep Tech
Business model
SaaS
Client focus
B2C

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Sep 2021 $0 — Stryker —
SERIES COther financing Oct 2020 $10M $100M Polaris Partners · OSF · The 4100 Group · SBVA —
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Gauss Surgical website traffic

Latest recorded traffic for Gauss Surgical is 620 monthly website visits, up 244.4% over the last three months. Gauss Surgical's team declined 12.5% over the past year.

Latest monthly visits620 3-month web change+244.4% 1-year team growth-12.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Gauss Surgical in the Menlo Park ecosystem

Live from Dealroom

The Gauss Surgical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

16 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Promus Ventures

Series A5 investors entered at this stage

  • StartX
  • Summation Health Ventures
  • Lifeforce Ventures
  • Providence Ventures
  • Jump Capital

Series B and later7 investors entered at this stage

  • SBVA
  • Northwell Health
  • Polaris Partners
  • OSF
  • Rex Health Ventures
  • Providence Healthcare Network
  • The 4100 Group

Other known investors3 additional known investors

  • Stanford University
  • Stryker
  • University of California, San Francisco
Team profiled 28 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Gauss Surgical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Gauss Surgical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.